Treatment of locally advanced and metastatic hepatocellular carcinoma (HCC) with gemcitabine (G) cisplatin (C) combination

被引：0
|
作者：
Granetto, C.
Fea, E.
Colantonio, I
Di Costanzo, G.
Garrone, O.
Gasco, M.
Occelli, M.
Heouaine, A.
Numico, G.
Merlano, M.
机构：
[1] Dept Med Oncol, Algiers, Algeria
[2] Dept Surg, Algiers, Algeria
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] Activity and tolerability of combination: capecitabine(c) plus gemcitabine(g) as first-line treatment in patients(pts) with locally advanced/metastatic pancreatic cancer
    Heras, P.
    Hatzopoulos, A.
    Karagianis, S.
    Mitsibounas, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 219 - 220
  • [22] Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
    J Millar
    P Scullin
    A Morrison
    B McClory
    L Wall
    D Cameron
    H Philips
    A Price
    D Dunlop
    M Eatock
    British Journal of Cancer, 2005, 93 : 1112 - 1116
  • [23] Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
    Millar, J
    Scullin, P
    Morrison, A
    McClory, B
    Wall, L
    Cameron, D
    Philips, H
    Price, A
    Dunlop, D
    Eatock, M
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1112 - 1116
  • [24] Early experience of combination treatment of sorafenib and radiotherapy in patients with advanced hepatocellular carcinoma (HCC)
    Seong, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] A phase II study of gemcitabine (G) in combination with liposomial doxorubicin (LD) for hepatocellular carcinoma (HCC) otherwise untreatable
    Pastorelli, D.
    Cartei, G.
    Zustovich, F.
    Ceravolo, R.
    Zovato, S.
    Farinati, F.
    Murrone, A.
    Zanus, G.
    Binato, S.
    Cillo, U.
    ANNALS OF ONCOLOGY, 2005, 16 : 158 - 158
  • [26] Patterns of care study on radiotherapy for locally advanced hepatocellular carcinoma (HCC)
    Seong, J.
    Lee, I.
    Shim, S.
    Lim, D.
    Kim, T.
    Kim, J.
    Jang, H.
    Kim, M.
    Chie, E.
    Kim, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S277 - S277
  • [27] Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma
    Yang, Qiao
    Nie, Yue Hua
    Cai, Man Bo
    Li, Zhi Min
    Zhu, Hong Bo
    Tan, Ye Ru
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 1191 - 1198
  • [28] Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study
    Ren, Xiang
    Tian, Yiqun
    Wang, Zhixian
    Wang, Jing
    Li, Xing
    Yin, Yisheng
    Chen, Ruibao
    Zhan, Ying
    Zeng, Xiaoyong
    BMC UROLOGY, 2022, 22 (01)
  • [29] Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study
    Xiang Ren
    Yiqun Tian
    Zhixian Wang
    Jing Wang
    Xing Li
    Yisheng Yin
    Ruibao Chen
    Ying Zhan
    Xiaoyong Zeng
    BMC Urology, 22
  • [30] Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer - Results of a phase II study
    Planchard, David
    Bourgeois, Hugues
    Adoun, Michele
    Paitel, Jean-Francois
    Blanc, Pierre
    Genet, Dominique
    Ferru, Aurelie
    Meurice, Jean-Chaude
    Deletage, Celine
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 345 - 351
12345